BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28418926)

  • 1. Urinary kallikrein 10 predicts the incurability of gastric cancer.
    Shimura T; Ebi M; Yamada T; Yamada T; Katano T; Nojiri Y; Iwasaki H; Nomura S; Hayashi N; Mori Y; Kataoka H; Moses MA; Joh T
    Oncotarget; 2017 Apr; 8(17):29247-29257. PubMed ID: 28418926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
    Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
    World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
    Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
    Ren C; Chen H; Han C; Fu D; Wang D; Shen M
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
    Alexopoulou DK; Papadopoulos IN; Scorilas A
    Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer.
    Duan J; Sun L; Huang H; Wu Z; Wang L; Liao W
    Mol Med Rep; 2016 Apr; 13(4):3027-35. PubMed ID: 26936091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
    BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
    Peng W; Wu G; Fan H; Wu J; Feng J
    Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
    Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
    World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
    Kolin DL; Sy K; Rotondo F; Bassily MN; Kovacs K; Brezden-Masley C; Streutker CJ; Yousef GM
    Biol Chem; 2014 Sep; 395(9):1087-93. PubMed ID: 25153389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
    Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
    Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
    Lim JB; Chung HW
    Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
    Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
    Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F
    Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
    Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
    Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.